EP2197494A2 - Funktionalisierte nanoteilchen zur hemmung der selectin-vermittelten zelladhäsion - Google Patents

Funktionalisierte nanoteilchen zur hemmung der selectin-vermittelten zelladhäsion

Info

Publication number
EP2197494A2
EP2197494A2 EP08801881A EP08801881A EP2197494A2 EP 2197494 A2 EP2197494 A2 EP 2197494A2 EP 08801881 A EP08801881 A EP 08801881A EP 08801881 A EP08801881 A EP 08801881A EP 2197494 A2 EP2197494 A2 EP 2197494A2
Authority
EP
European Patent Office
Prior art keywords
group
nanoparticle according
heterocyclic compound
selectin
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08801881A
Other languages
English (en)
French (fr)
Inventor
Hans-Ulrich Reissig
Jens Dernedde
Sabine Schlecht
Meike Roskamp
Sven Enders
Shahla Yekta
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charite Universitaetsmedizin Berlin
Freie Universitaet Berlin
Original Assignee
Charite Universitaetsmedizin Berlin
Freie Universitaet Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charite Universitaetsmedizin Berlin, Freie Universitaet Berlin filed Critical Charite Universitaetsmedizin Berlin
Priority to EP08801881A priority Critical patent/EP2197494A2/de
Publication of EP2197494A2 publication Critical patent/EP2197494A2/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
EP08801881A 2007-09-05 2008-09-05 Funktionalisierte nanoteilchen zur hemmung der selectin-vermittelten zelladhäsion Withdrawn EP2197494A2 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP08801881A EP2197494A2 (de) 2007-09-05 2008-09-05 Funktionalisierte nanoteilchen zur hemmung der selectin-vermittelten zelladhäsion

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07017412A EP2033660A1 (de) 2007-09-05 2007-09-05 Funktionalisierte Nanopartikel zur Hemmung Selectin-vermittelter Zelladhäsion
PCT/EP2008/007288 WO2009030492A2 (en) 2007-09-05 2008-09-05 Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion
EP08801881A EP2197494A2 (de) 2007-09-05 2008-09-05 Funktionalisierte nanoteilchen zur hemmung der selectin-vermittelten zelladhäsion

Publications (1)

Publication Number Publication Date
EP2197494A2 true EP2197494A2 (de) 2010-06-23

Family

ID=39099812

Family Applications (2)

Application Number Title Priority Date Filing Date
EP07017412A Withdrawn EP2033660A1 (de) 2007-09-05 2007-09-05 Funktionalisierte Nanopartikel zur Hemmung Selectin-vermittelter Zelladhäsion
EP08801881A Withdrawn EP2197494A2 (de) 2007-09-05 2008-09-05 Funktionalisierte nanoteilchen zur hemmung der selectin-vermittelten zelladhäsion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EP07017412A Withdrawn EP2033660A1 (de) 2007-09-05 2007-09-05 Funktionalisierte Nanopartikel zur Hemmung Selectin-vermittelter Zelladhäsion

Country Status (2)

Country Link
EP (2) EP2033660A1 (de)
WO (1) WO2009030492A2 (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8295078B2 (en) 2006-05-02 2012-10-23 Micron Technology, Inc. Semiconductor memory cell and array using punch-through to program and read same
US8351266B2 (en) 2009-04-27 2013-01-08 Micron Technology, Inc. Techniques for controlling a direct injection semiconductor memory device

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2123269A1 (de) * 2008-05-21 2009-11-25 Freie Universität Berlin Mit sulfatierten Aminalkoholen funktionalisierte Nanopartikel zur Hemmung selectinvermittelter Zelladhäsion
DE102011101952A1 (de) * 2011-05-18 2012-11-22 Charité - Universitätsmedizin Berlin Mit dendritischem Polyglycerolsulfat funktionalisierte Nanopartikel
CN107837389B (zh) 2014-10-03 2022-12-13 纳米提克斯有限责任公司 用于抑制可溶生物分子的生物活性的组合物以及方法
JP7370691B2 (ja) * 2015-06-30 2023-10-30 ナノティックス，エルエルシー スカベンジャー粒子に関連する組成物及び方法
JP2018522026A (ja) * 2015-07-29 2018-08-09 ナノティックス，エルエルシー 可溶性生体分子を捕捉するためのモジュラー組成物及びそれと関連する方法
WO2017176762A1 (en) * 2016-04-06 2017-10-12 Nanotics, Llc Particles comprising subparticles or nucleic acid scaffolds
WO2018129207A1 (en) 2017-01-04 2018-07-12 Nanotics, Llc Methods for assembling scavenging particles

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0025414D0 (en) * 2000-10-16 2000-11-29 Consejo Superior Investigacion Nanoparticles
US20060084705A1 (en) * 2000-11-24 2006-04-20 Frank Caruso Phase transfer of nanoparticles
US20050003459A1 (en) * 2002-01-30 2005-01-06 Krutzik Siegfried Richard Multi-purpose optical analysis disc for conducting assays and related methods for attaching capture agents
WO2006037081A2 (en) * 2004-09-28 2006-04-06 The Regents Of The University Of California Nanoparticle radiosensitizers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO2009030492A2 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8295078B2 (en) 2006-05-02 2012-10-23 Micron Technology, Inc. Semiconductor memory cell and array using punch-through to program and read same
US8351266B2 (en) 2009-04-27 2013-01-08 Micron Technology, Inc. Techniques for controlling a direct injection semiconductor memory device

Also Published As

Publication number Publication date
WO2009030492A2 (en) 2009-03-12
EP2033660A1 (de) 2009-03-11
WO2009030492A3 (en) 2009-09-03

Similar Documents

Publication Publication Date Title
WO2009030492A2 (en) Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion
CN103864677B (zh) 硫代乙酸盐化合物、组合物及其使用方法
CN103608139B (zh) 表面改性的重金属纳米粒子、组合物及其用途
CN102939279B (zh) 苯基硫代乙酸酯/盐化合物、组合物及其使用方法
JP2013527157A (ja) プロドラッグ組成物、プロドラッグナノ粒子およびその使用方法
Roskamp et al. Multivalent interaction and selectivities in selectin binding of functionalized gold colloids decorated with carbohydrate mimetics
JP2007527881A (ja) 薬学的に活性な物質を細胞特異的に濃縮するためのタンパク質ベースのナノ粒子形態の支持システム
Morgese et al. Ultrastable suspensions of polyoxazoline-functionalized ZnO single nanocrystals
US20160251320A1 (en) Compounds
JP2022552757A (ja) カンプトテシン類医薬品及びその抗体複合体
Assali et al. Combretastatin A4-camptothecin micelles as combination therapy for effective anticancer activity
US20120269903A1 (en) Novel mannopyranoside derivatives with anticancer activity
CN106083925B (zh) 一种二膦酸化合物及其制备方法与应用
Champagne et al. Synthesis and Unprecedented Complexation Properties of β-Cyclodextrin-Based Ligand for Lanthanide Ions
CN102089276A (zh) 酶结构、活性和/或表达水平的调节
ES2903387T3 (es) Materiales magnéticos biocompatibles
Dong et al. Development of a novel sialic acid-conjugated camptothecin prodrug for enhanced cancer chemotherapy
Sarmento et al. Biomedical applications of functionalized nanomaterials: concepts, development and clinical translation
EP2123269A1 (de) Mit sulfatierten Aminalkoholen funktionalisierte Nanopartikel zur Hemmung selectinvermittelter Zelladhäsion
CN109152750A (zh) 用于增殖性疾病的组合疗法
CN108976318A (zh) 单-6-（生物素酰胺基）-6-脱氧-β-环糊精及其制备方法和应用
CN117414435A (zh) 一种核酸适配体偶联药物及其应用
JP2011515330A (ja) 改良抗腫瘍治療剤
CN102952207B (zh) 6-(1-甲基-β-咔啉-3-羧酸乙酰基)-6-脱氧-β-环糊精及其与阿霉素超分子包结配合物的制备和应用
KR20190075389A (ko) 항암제가 담지된 나노구조체를 유효성분으로 포함하는 간암 치료용 약학조성물

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100331

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: YEKTA, SHAHLA

Inventor name: ENDERS, SVEN

Inventor name: ROSKAMP, MEIKE

Inventor name: SCHLECHT, SABINE

Inventor name: DERNEDDE, JENS

Inventor name: REISSIG, HANS-ULRICH

DAX Request for extension of the european patent (deleted)
17Q First examination report despatched

Effective date: 20140319

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20140401